University of New Mexico
Data updated
Pioneer in modern American psychedelic research through Rick Strassman's DMT and psilocybin studies in the 1990s — among the first human psychedelic research since the 1970s. Today, UNM Health Sciences conducts active trials of psilocybin, MDMA, and ketamine for depression, PTSD, alcohol use disorder, and methamphetamine addiction.
Academic Research
0 papersPublished Papers
0
Trial Involvement
9
Distinct Focus Topics
0
Latest Publication
Unknown
Research journey
Built from the 8 trials University of New Mexico has sponsored, placed at the date each one started.
Quick Facts
- Type
- Other
- HQ
- University of New Mexico, Albuquerque, United States
- Website
- Visit
Research Landscape
What the registered trials University of New Mexico sponsors or participates in look like when you line them up. Counts come from Blossom’s trial records as of August 2026.
What's live right now, and what stopped?
SourcedRegistry status of all 9 University of New Mexico trials Blossom tracks. Orange marks trials recruiting or opening.
Don't read stopped trials as failures: trials end early for funding, recruitment, and strategy reasons too. Status is as last synced from the registry; some 'recruiting' trials may already have finished.
Sponsored Trials
8Assessing of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies
- Start Date
- Compounds
- Psilocybin
Precision Phenotyping of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies
- Start Date
- Compounds
- Psilocybin
Group Psilocybin-Assisted Therapy for Post-Traumatic Stress Disorder
- Start Date
- Compounds
- Psilocybin
MDMA for Co-occurring PTSD and OUD After Childbirth
- Start Date
- Compounds
- MDMA
Connectivity Changes Associated With Ketamine Assisted Psychotherapy for PTSD
- Start Date
- Compounds
- Ketamine
EEG Characteristics in ECT
- Start Date
- Compounds
- Ketamine
Spreading Depolarization and Ketamine Suppression
- Start Date
- Compounds
- Ketamine
Effects and Therapeutic Potential of Psilocybin in Alcohol Dependence
- Start Date
- Compounds
- Psilocybin
Where this pipeline sits in the field
University of New Mexico runs late-stage trials that Blossom ranks by how soon a catalyst is expected, alongside every other Phase 2 and Phase 3 study in the field.
Collaborated Trials
1Recent activity
- StartedGroup Psilocybin-Assisted Therapy for Post-Traumatic Stress Disorder (NCT07506395, psilocybin)
- StartedMDMA for Co-occurring PTSD and OUD After Childbirth (NCT05219175, mdma)
- WithdrawnConnectivity Changes Associated With Ketamine Assisted Psychotherapy for PTSD (NCT06036511, ketamine)
- CompletedA Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence (NCT02061293, psilocybin)
- CompletedEEG Characteristics in ECT (NCT04022226, ketamine)
- StartedEEG Characteristics in ECT (NCT04022226, ketamine)
- CompletedSpreading Depolarization and Ketamine Suppression (NCT02501941, ketamine)
- StartedSpreading Depolarization and Ketamine Suppression (NCT02501941, ketamine)